📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

17q21 variant increases the risk of exacerbations in asthmatic children despite inhaled corticosteroids use. (2018)

First Author: Farzan N

Attributed to: Centre for Drug Safety Science (CDSS) funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1111/all.13499

PubMed Identifier: 29885281

Publication URI: http://europepmc.org/abstract/MED/29885281

Type: Journal Article/Review

Volume: 73

Parent Publication: Allergy

Issue: 10

ISSN: 0105-4538